Novo Seeks To Halt Caraco Launch Of Generic Prandin
Novo Nordisk Inc. has asked a federal court to stop Caraco Pharmaceutical Laboratories Ltd. and its majority shareholder Sun Pharmaceutical Industries Ltd. from launching a generic version of Novo's diabetic drug...To view the full article, register now.
Already a subscriber? Click here to view full article